Cancer Vaccines
Investigators at Mie University publish new data on cancer vaccines
Published in Vaccine Weekly, January 17th, 2007
Fresh data on cancer are presented in the report "HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan." According to a study from Japan, "We developed a complex of tumor antigen protein with a novel nanoparticle antigen delivery system of cholesteryl pullulan (CHP). To target HER2 antigen, we prepared truncated HER2 protein 1-146 (146HER2) complexed with CHP, the CHP-HER2 vaccine."
"We designed a clinical study to assess the safety of the vaccine and HER2-specific T-cell immune responses measured by the newly developed enzyme-linked immunospot assay with mRNA-transduced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-01-17)
More Articles from Vaccine Weekly
- Influenza Vaccine
GSK Biologicals gets positive opinion from CHMP for flu pandemic vaccine program - Anthrax Vaccine
U.S. Health & Human Services cancels VaxGen's anthrax vaccine contract - Botulism
Study reveals molecular basis of botulism toxin's deadly activity - Breast Cancer
Breast cancer vaccine is one step closer to reality - Breast Cancer
Pharmexa-Epimmune and Ichor Medical Systems enter into a collaborative agreement - Business & Finance
Microbix reports sales growth, product and infrastructure investment in FY06 - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
